Sangeetha Srinivasan

ChemistryBiochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species”.

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534654

N/A

1.1DataRank · unranked

26 citations

Nathan A. Yee, Michael Zakharian, Maša Alečković, Amir Mahmoodi, Tri‐Hung Nguyen +2 more

Development of a First-in-Class Click Chemistry–Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2539

N/A

0.284DataRank · unranked

5 citations

Nathan K. Yee, Maša Alečković, Michael Zakharian, Amir Mahmoodi, Stefanie Wagner +5 more

Interim phase 1 results for SQ3370 in advanced solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3085

N/A

0DataRank · unranked

4 citations

Kathleen Batty, Maša Alečković, Vivek A. Bhadri, Nam Q. Bui, Alexander Guminski +10 more

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions

Advanced Therapeutics(2021)10.1002/adtp.202000243

N/A

0DataRank · unranked

75 citations

Nathan A. Yee, Kui Wu, Michael Zakharian, Amir Mahmoodi, Maksim Royzen +2 more

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors

medRxiv(2025)10.1101/2025.06.02.25328445

N/A

0DataRank · unranked

2 citations

Esteban Abella, Stefan Wieland, Thu‐Ha Nguyen, Sangeetha Srinivasan, M. Alečković +10 more

953 Treatment with SQ3370, a doxorubicin-based therapeutic, corresponds with immunomodulation of the tumor microenvironment

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0953

N/A

0DataRank · unranked

0 citations

Sangeetha Srinivasan, Jesse M. McFarland, Leslie Priddy, Matthew Tso, Jose Mejia Oneto +1 more

695 Combination of click chemistry-based SQ3370 with immunotherapies enhances antitumor effect in murine tumors with minimized systemic toxicity

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.695

N/A

0DataRank · unranked

0 citations

Sangeetha Srinivasan, Michael Zakharian, Nathan K. Yee, Jesse M. McFarland, Jose Mejia Oneto +1 more